Amgen bone drug boosts density
- Share via
From Times Wire Services
Amgen Inc. said its experimental drug for osteoporosis boosted bone density among postmenopausal women in a clinical trial.
The treatment, denosumab, was more effective than a placebo at increasing bone density in a study of 332 women, the Thousand Oaks-based company said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
